Please assess the completion status of the following clinical trial:

Trial Title: Malignant Obstruction ZILVER Against Routine Therapy (MOZART I)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Unresectable malignancy of the extrahepatic bile duct~Exclusion Criteria:~* Age below 21 years~* Pregnancy~* Active alcohol or drug abuse~* Simultaneously participating in another investigational drug or device study.~* Allergy to stainless steel or nitinol~* Active cholangitis~* Brachytherapy~* Unable or unwilling to comply with follow up

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 6 mm Zilver (Type: EXPERIMENTAL): 6 mm Nitinol Zilver Stent
- 10 mm Zilver (Type: EXPERIMENTAL): 10 mm Nitinol Zilver Stent
- 10 mm Wallstent (Type: ACTIVE_COMPARATOR): 10 mm Stainless Steel Wallstent

Based on this trial design, predict the completion outcome and termination type (if applicable).